Low-dose naltrexone

Low-dose naltrexone (LDN) is a prescription medication used to treat various conditions by modulating the immune system and reducing inflammation. Studies have found that LDN can help manage chronic pain, improve symptoms in patients with fibromyalgia, and benefit those suffering from rheumatological diseases such as lupus and multiple sclerosis. Additionally, research indicates potential benefits for post-COVID-19 condition symptoms and suggests a promising role in immune-related diseases and cancer therapy. A common side effect of LDN is headache, which was observed in some studies. While the evidence supports its use across several conditions, more extensive clinical trials are needed to fully establish its efficacy and safety profile.

Sources

• Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization. (PMID:30248938)
• Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review. (PMID:32845365)
• Low-Dose Naltrexone in Rheumatological Diseases. (PMID:37223594)
• Low-dose Naltrexone Improves post-COVID-19 condition Symptoms. (PMID:38267326)
• Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy. (PMID:29885638)
• The Safety and Efficacy of Low-Dose Naltrexone in Patients with Fibromyalgia: A Systematic Review. (PMID:36974308)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._